Sinobioway Bio-medicine is looking for an engineering, procurement and construction (EPC) firm for a $300 million contract developing and manufacturing organization (CDMO) complex. The company plans to expand its active pharmaceutical ingredients and preparations market by building a grassroot complex in Hefei city of Anhui in China. Currently, the project is in a planning and scheduling stage; however, the company hopes to begin the site preparation work by the end of 2019, and operation is likely to commence in early 2021.
(All Fields Required)
Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.
×Contact Us
For More Info!
